The Ritedose Corporation (United States) has no DMF, CEP or site registration linked in our records. 8 FDA enforcement records are linked to it.

Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records

Cite as: PharmaTek, “The Ritedose Corporation: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/the-ritedose-corporation

Overview

The Ritedose Corporation is a pharmaceutical company headquartered in Columbia, United States.

FDA compliance signals

8 FDA enforcement records linked to this company.

  • recall — Class II2026-11-04

    Failed Impurities/Degradation Specification

  • 4832025-02-28

    Investigations of discrepancies, failures

  • 4832025-02-28

    Defined areas of adequate size for operations

  • 4832025-02-28

    Validation lacking for sterile drug products

  • recall — Class II2023-08-09

    CGMP deviation: product released prior to supplier approval.

  • recall — Class III2022-04-13

    Labeling: Incorrect Barcode: Product barcode incorrectly identifies the product as rocuronium bromide injection 100 mg per 10 mL instead of sodium chloride injection 23.4%, 120 mEq per 30 mL.

  • 4832022-03-22

    Investigations of discrepancies, failures

  • 4832017-03-03

    Following/documenting laboratory controls

For suppliers

Is this The Ritedose Corporation?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.

Need suppliers found and checked?

The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.